tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Keyur Parekh, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).
Analyst Keyur Parekh, currently employed carries an average stock price target met ratio of 33.33% that have a potential upside of 15.82% achieved within 243 days.
Keyur Parekh’s has documented 19 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 11/19/2018. The price target of $77.42 was fulfilled within 211 days with a profit of $12.9 (19.99%) receiving and performance score of 0.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
16 days ago
(06-Nov-2024)
1/11 (9.09%)
$82.61 (131.40%)
2587
Buy
$95
$31.77 (50.25%)
$66
3 months 10 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
360
Buy
$85
$21.77 (34.43%)
$80
5 months 23 days ago
(30-May-2024)
4/4 (100%)
$8.23 (10.72%)
390
Buy
$82
$18.77 (29.69%)
$80
6 months 27 days ago
(26-Apr-2024)
4/4 (100%)
$6.83 (9.09%)
296
Buy
$85
$21.77 (34.43%)
9 months 30 days ago
(23-Jan-2024)
1/11 (9.09%)
$19.26 (29.30%)
210
What Year was the first public recommendation made by Keyur Parekh?
